(44- 20) 74 18 84 00 Fax (44- 20) 74 18 84 16 E- mail: mail@ emea. europa. eu http: // www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Virkningen blev hovedsagelig bedømt på forskellen i det antal leverlæsioner, der blev fundet ved den foregående scanning og ved anvendelse af TESLASCAN under MRI.
The main measure of effectiveness was the difference in the number of liver lesions detected in the previous scan and when using TESLASCAN during MRI.